Nicholass Story And What You Should Know Now-月丘うさぎ

UnCategorized Nicholas Shannon is a happy, sweet, well-mannered little boy. He was also healthy. His parents, Chris and Karen, could not have predicted the evil turn their life has taken in the last three weeks. A headache became an MRI. That MRI showed a tumor, racquetball-sized on the right frontal lobe of Nicholas’s brain. After invasive seven-hour brain surgery, Nicholas has been diagnosed with the worst possible brain cancer a human can have. This tumor is extremely aggressive and does not respond well to medical interventions. Nicholas will now begin very intense chemotherapy and radiation treatments. His future will be determined by how his cancer responds to this therapy, but the odds are low for long-term survival. Nicholas’s younger brother, Gregory, idolizes him. His mother will give birth in August, to a little girl they named Emery. This summer promised receipts for tiny pink dresses, baby shower invitations and suitcases packed for the hospital. Those suitcases are no longer destined for the hospital Karen chose to give birth. Now they’re packed for the facility they chose to fight for their son’s life. All proceeds from the Hope for Nicholas Benefit Concert will be spent on this family’s fight for their child. We are also accepting additional donations. It is our sincere hope that our .munity rises up to meet him and carry him during this fragile stage of his very young life. Oxford Journals on diagnosis: The median survival of glioblastoma patients is 12 months. However, 35% of the patients survives for more than 3 years and are referred to as long-term survivors. The clinical and molecular factors that contribute to long-term survival are still unknown. Glioblastoma multiform is the most .mon and most malignant primary tumor of the brain and associated with one of the worst 5 year survival rates among all human cancers. Despite Multimodal aggressive treatment, .prising surgical resection, local radiotherapy and systemic chemotherapy, the median survival time after diagnosis is still in the range of just 12 months Smith and Jenkins, 2000, with population-based studies indicating even shorter median survival Ohgaki ET AL 2004. Nevertheless, a small fraction of Glioblastoma patients survive for more than 36 months. These patients are referred to as long-term survivors. Most tumors originate in a sporadic fashion without any known genetic predisposition. Harvard MGH Brain Tumor Center on surgery: The first step in therapy is maximal feasible removal of tumor tissue. Surgeons believe that patients with smaller amounts of tumor when they start other treatments will have a better prognosis. Also, radiation therapy is more easily tolerated when the pressure from the tumor can be reduced. There is great variability in the amount of tumor that can be safely removed from the brain of a patient. The variability is based mainly on the location of the tumor. For instance, tumors in some brain areas can be removed with very low risk, while in other brain areas surgery is too risky to contemplate. The decision about the benefit and risk of surgical removal is one that experienced brain tumor neurosurgeons make every day. The underlying principle is that the surgery should not worsen the patient’s condition. The goal is for the patient to be the same or better after recovering from brain tumor removal. When a tumor is located in a sensitive area of the brain, a biopsy is performed with a small needle, thereby avoiding further damage to brain function. With modern neuro-imaging techniques such as MRI scans, it is possible for doctors to have a high level of confidence that a brain tumor is present prior to biopsy. In that case, it is safe to perform a major surgical resection at the same time as obtaining tumor tissue for the pathologist to examine. In some cases, however, it is necessary to perform a needle biopsy first, and later proceed to a full-scale surgery. A preliminary diagnosis frozen section diagnosis is made by the neuron pathologist during the surgery in order to help the neurosurgeon know what type of tumor is present. The patient and their family are informed of this preliminary diagnosis immediately after surgery. However, further re.mendations about treatment are not made until the final pathology report is available. The final report requires a minimum of 2 working days after surgery. In difficult cases, the final report can take a week. It is not un.mon for small, but important, changes to be made in the diagnosis once all of the biopsy sections have been examined. An MRI scan is usually obtained within 3 days after tumor removal. This "post-op" MRI serves as a baseline for future .parison. Harvard MGH Brain Tumor Center on radiation therapy: Radiation therapy is an important part of the treatment of high-grade gliomas. In standard therapy situations, patients begin radiation treatments within 2 to 4 weeks after tumor resection. A physician who supervises radiation treatments is called a radiation oncologist. Following a simulation session in which the radiation oncologist plans the shape of the radiation beam as well as dose, treatments are given daily, Monday through Friday, for 4 to 6 weeks. Each treatment takes only a few minutes. During radiation, patients are seen weekly by the radiation oncologist, and a nurse is available for questions every day. Most patients feel better during radiation therapy if they are taking a small dose of a steroid which reduces brain swelling, called Decadron also called dexamethasone. There are usually no immediate side effects during each treatment. As the treatment progresses, hair loss will occur over the area where the radiation beam passes into the tumor. Most patients experience some fatigue by the second or third week. For many patients, a 30 minute nap is helpful every afternoon. There are a number of long term side effects from radiation therapy, ranging from those that are a minor nuisance to one that can produce major health problems. Fortunately, serious side effects are rare. The potential risks of radiation therapy are outweighed by the known risk of not treating the tumor. The radiation oncologist will describe these risks prior to starting therapy. An MRI is usually obtained about 2 to 4 weeks after the end of radiation therapy in order to judge the effect of treatment. Most of the time this scan will show no change from the post-operative MRI, which is good. Some shrinkage is even better. Growth during radiation therapy is an unwanted sign of an aggressive tumor. Nicholas has begun 7 weeks of daily radiation treatments in Oklahoma City About the Author: 相关的主题文章: